Sumitomo Mitsui Trust Holdings Inc. Makes New Investment in Celsius Holdings, Inc. (NASDAQ:CELH)

Sumitomo Mitsui Trust Holdings Inc. bought a new position in shares of Celsius Holdings, Inc. (NASDAQ:CELH) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 342,558 shares of the company’s stock, valued at approximately $18,676,000. Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.15% of Celsius at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC boosted its stake in shares of Celsius by 633.9% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,422,367 shares of the company’s stock worth $77,547,000 after buying an additional 1,228,560 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Celsius by 18.7% during the 3rd quarter. Vanguard Group Inc. now owns 4,846,599 shares of the company’s stock worth $831,676,000 after buying an additional 762,087 shares during the last quarter. Braun Stacey Associates Inc. boosted its stake in shares of Celsius by 192.5% during the 3rd quarter. Braun Stacey Associates Inc. now owns 634,863 shares of the company’s stock worth $108,942,000 after buying an additional 417,825 shares during the last quarter. Lord Abbett & CO. LLC acquired a new position in shares of Celsius during the 3rd quarter worth about $37,873,000. Finally, Arcus Capital Partners LLC boosted its stake in shares of Celsius by 200.0% during the 4th quarter. Arcus Capital Partners LLC now owns 319,257 shares of the company’s stock worth $17,406,000 after buying an additional 212,838 shares during the last quarter. Institutional investors own 60.95% of the company’s stock.

Insider Buying and Selling at Celsius

In other Celsius news, major shareholder Deborah Desantis sold 128,309 shares of the firm’s stock in a transaction that occurred on Wednesday, January 24th. The shares were sold at an average price of $43.96, for a total value of $5,640,463.64. Following the sale, the insider now owns 31,096,560 shares in the company, valued at $1,367,004,777.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Celsius news, major shareholder Dean Desantis sold 100,000 shares of the company’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $95.75, for a total transaction of $9,575,000.00. Following the sale, the insider now owns 219,257 shares of the company’s stock, valued at $20,993,857.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Deborah Desantis sold 128,309 shares of the company’s stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $43.96, for a total transaction of $5,640,463.64. Following the transaction, the insider now owns 31,096,560 shares in the company, valued at approximately $1,367,004,777.60. The disclosure for this sale can be found here. Insiders have sold 908,742 shares of company stock worth $54,790,179 over the last quarter. Corporate insiders own 2.20% of the company’s stock.

Wall Street Analysts Forecast Growth

CELH has been the subject of several recent analyst reports. Roth Mkm raised their target price on shares of Celsius from $90.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, March 14th. Maxim Group raised their target price on shares of Celsius from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Morgan Stanley reiterated an “equal weight” rating and issued a $75.00 target price on shares of Celsius in a research note on Wednesday, March 27th. Stifel Nicolaus raised their target price on shares of Celsius from $67.00 to $90.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Finally, Piper Sandler increased their price target on shares of Celsius from $76.00 to $90.00 and gave the company an “overweight” rating in a report on Friday, March 1st. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $85.10.

Celsius Trading Up 1.4 %

Shares of CELH opened at $69.79 on Tuesday. Celsius Holdings, Inc. has a 12 month low of $29.91 and a 12 month high of $99.62. The firm’s 50 day moving average is $79.01 and its 200-day moving average is $64.43. The stock has a market capitalization of $16.12 billion, a PE ratio of 90.25, a P/E/G ratio of 2.01 and a beta of 1.86.

Celsius (NASDAQ:CELH) last announced its quarterly earnings data on Thursday, February 29th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The business had revenue of $347.44 million for the quarter, compared to analysts’ expectations of $326.77 million. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The firm’s quarterly revenue was up 95.2% compared to the same quarter last year. During the same period last year, the firm posted $0.01 earnings per share. Equities research analysts predict that Celsius Holdings, Inc. will post 1.09 earnings per share for the current fiscal year.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.